Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), both of which are known to block the renin-angiotensin system (RAS), also might affect an individual's susceptibility to COVID-19 and further worsen its severity (32–35). This evidence concerns the gene ACE and COVID-19.